These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3410490)

  • 1. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L; Thiry E; Füst G
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
    Medof ME; Prince GM; Oger JJ
    Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA; Virella G
    Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition for immune complexes by red cells in human blood.
    Medof ME; Oger JJ
    J Clin Lab Immunol; 1982 Jan; 7(1):7-13. PubMed ID: 7069779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activation.
    Schifferli JA; Peters DK
    Clin Exp Immunol; 1983 Dec; 54(3):827-33. PubMed ID: 6228359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC; Kimberly RP; Taylor RP
    Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complement receptor for opsonized immune complexes on erythrocytes from Oncorhynchus mykiss but not Ictalarus punctatus.
    Schraml B; Baker MA; Reilly BD
    Mol Immunol; 2006 Apr; 43(10):1595-603. PubMed ID: 16271392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1989 Nov; 78(2):201-6. PubMed ID: 12412749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
    Medof ME; Scarborough D; Miller G
    Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.
    Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA
    Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of immune complexes in disseminated neuroblastoma with serum antibody to bovine serum albumin.
    Beck DA; Rossen RD; Cangir A; DuBois DB
    Cancer Res; 1983 Feb; 43(2):879-85. PubMed ID: 6336661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.
    Birmingham DJ; Hebert LA; Cosio FG; VanAman ME
    J Lab Clin Med; 1990 Aug; 116(2):242-52. PubMed ID: 1697615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific in vitro antibody-mediated retention of bovine serum albumin by porcine hyaline articular cartilage.
    Aston WP; Ward TL; Cooke TD
    Clin Exp Immunol; 1983 May; 52(2):280-6. PubMed ID: 6861375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
    Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
    Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes.
    Bradley AJ; Scott MD
    Am J Hematol; 2007 Nov; 82(11):970-5. PubMed ID: 17654505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.